356 related articles for article (PubMed ID: 6140202)
1. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
[TBL] [Abstract][Full Text] [Related]
2. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.
Malchow H; Steinhardt HJ; Lorenz-Meyer H; Strohm WD; Rasmussen S; Sommer H; Jarnum S; Brandes JW; Leonhardt H; Ewe K
Scand J Gastroenterol; 1990 Mar; 25(3):235-44. PubMed ID: 1969678
[TBL] [Abstract][Full Text] [Related]
5. National Cooperative Crohn's Disease Study: study design and conduct of the study.
Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
[TBL] [Abstract][Full Text] [Related]
6. National Cooperative Crohn's Disease Study: results of drug treatment.
Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
[TBL] [Abstract][Full Text] [Related]
7. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
Gross V; Andus T; Caesar I; Bischoff SC; Lochs H; Tromm A; Schulz HJ; Bär U; Weber A; Gierend M; Ewe K; Schölmerich J
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):905-9. PubMed ID: 8889459
[TBL] [Abstract][Full Text] [Related]
8. Alternate-day prednisone treatment and treatment maintenance in Crohn's disease.
Bello C; Goldstein F; Thornton JJ
Am J Gastroenterol; 1991 Apr; 86(4):460-6. PubMed ID: 1672787
[TBL] [Abstract][Full Text] [Related]
9. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
Gross V; Andus T; Fischbach W; Weber A; Gierend M; Hartmann F; Schölmerich J
Z Gastroenterol; 1995 Oct; 33(10):581-4. PubMed ID: 7502549
[TBL] [Abstract][Full Text] [Related]
10. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
Singleton JW
Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133
[No Abstract] [Full Text] [Related]
11. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
[TBL] [Abstract][Full Text] [Related]
12. [Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn's disease: a prospective multicenter controlled trial in 155 patients].
Modigliani R; Pieddeloup C; Hecketsweiler P; Descos L; Lerebours E; Vernisse B; Costil V; Bitoun A; Lacroute JM; Maire P
Gastroenterol Clin Biol; 1983; 7(8-9):683-92. PubMed ID: 6352383
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart AH; Hemphill D; Greenberg GR
Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
[TBL] [Abstract][Full Text] [Related]
14. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
Singleton JW; Law DH; Kelley ML; Mekhjian HS; Sturdevant RA
Gastroenterology; 1979 Oct; 77(4 Pt 2):870-82. PubMed ID: 38177
[TBL] [Abstract][Full Text] [Related]
15. Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
Tremaine WJ; Hanauer SB; Katz S; Winston BD; Levine JG; Persson T; Persson A;
Am J Gastroenterol; 2002 Jul; 97(7):1748-54. PubMed ID: 12135030
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine-related pancreatitis in patients with Crohn's disease.
Sturdevant RA; Singleton JW; Deren JL; Law DH; McCleery JL
Gastroenterology; 1979 Oct; 77(4 Pt 2):883-6. PubMed ID: 38178
[TBL] [Abstract][Full Text] [Related]
17. Favorable effects of sulfasalazine on small bowel Crohn's disease: a long-term study.
Goldstein F; Farquhar S; Thornton JJ; Abramson J
Am J Gastroenterol; 1987 Sep; 82(9):848-53. PubMed ID: 2888305
[TBL] [Abstract][Full Text] [Related]
18. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
19. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.
Present DH; Korelitz BI; Wisch N; Glass JL; Sachar DB; Pasternack BS
N Engl J Med; 1980 May; 302(18):981-7. PubMed ID: 6102739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
